ID   TNFL6_RAT               Reviewed;         278 AA.
AC   P36940;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   29-MAY-2024, entry version 181.
DE   RecName: Full=Tumor necrosis factor ligand superfamily member 6;
DE   AltName: Full=CD95 ligand;
DE            Short=CD95-L;
DE   AltName: Full=Fas antigen ligand;
DE            Short=Fas ligand;
DE            Short=FasL;
DE   AltName: CD_antigen=CD178;
DE   Contains:
DE     RecName: Full=Tumor necrosis factor ligand superfamily member 6, membrane form;
DE   Contains:
DE     RecName: Full=Tumor necrosis factor ligand superfamily member 6, soluble form;
DE     AltName: Full=Receptor-binding FasL ectodomain;
DE     AltName: Full=Soluble Fas ligand;
DE              Short=sFasL;
DE   Contains:
DE     RecName: Full=ADAM10-processed FasL form;
DE              Short=APL;
DE   Contains:
DE     RecName: Full=FasL intracellular domain;
DE              Short=FasL ICD;
DE     AltName: Full=SPPL2A-processed FasL form;
DE              Short=SPA;
GN   Name=Faslg; Synonyms=Apt1Lg1, Cd95l, Fasl, Tnfsf6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INDUCTION.
RX   PubMed=7505205; DOI=10.1016/0092-8674(93)90326-l;
RA   Suda T., Takahashi T., Golstein P., Nagata S.;
RT   "Molecular cloning and expression of the Fas ligand, a novel member of the
RT   tumor necrosis factor family.";
RL   Cell 75:1169-1178(1993).
CC   -!- FUNCTION: Cytokine that binds to TNFRSF6/FAS, a receptor that
CC       transduces the apoptotic signal into cells (PubMed:7505205). Involved
CC       in cytotoxic T-cell-mediated apoptosis, natural killer cell-mediated
CC       apoptosis and in T-cell development (PubMed:7505205). Initiates
CC       fratricidal/suicidal activation-induced cell death (AICD) in antigen-
CC       activated T-cells contributing to the termination of immune responses
CC       (By similarity). TNFRSF6/FAS-mediated apoptosis has also a role in the
CC       induction of peripheral tolerance (By similarity). Binds to
CC       TNFRSF6B/DcR3, a decoy receptor that blocks apoptosis (By similarity).
CC       {ECO:0000250|UniProtKB:P41047, ECO:0000250|UniProtKB:P48023,
CC       ECO:0000269|PubMed:7505205}.
CC   -!- FUNCTION: [Tumor necrosis factor ligand superfamily member 6, soluble
CC       form]: Induces FAS-mediated activation of NF-kappa-B, initiating non-
CC       apoptotic signaling pathways. Can induce apoptosis but does not appear
CC       to be essential for this process. {ECO:0000250|UniProtKB:P41047}.
CC   -!- FUNCTION: [FasL intracellular domain]: Cytoplasmic form induces gene
CC       transcription inhibition. {ECO:0000250|UniProtKB:P48023}.
CC   -!- SUBUNIT: Homotrimer. Interacts with ARHGAP9, BAIAP2L1, BTK, CACNB3,
CC       CACNB4, CRK, DLG2, DNMBP, DOCK4, EPS8L3, FGR, FYB1, FYN, HCK, ITK,
CC       ITSN2, KALRN, LYN, MACC1, MIA, MPP4, MYO15A, NCF1, NCK1, NCK2, NCKIPSD,
CC       OSTF1, PIK3R1, PSTPIP1, RIMBP3C, SAMSN1, SH3GL3, SH3PXD2B, SH3PXD2A,
CC       SH3RF2, SKAP2, SNX33, SNX9, SORBS3, SPTA1, SRC, SRGAP1, SRGAP2, SRGAP3,
CC       TEC, TJP3 and YES1. {ECO:0000250|UniProtKB:P48023}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7505205};
CC       Single-pass type II membrane protein {ECO:0000255}. Cytoplasmic vesicle
CC       lumen {ECO:0000250|UniProtKB:P48023}. Lysosome lumen
CC       {ECO:0000250|UniProtKB:P48023}. Note=Colocalizes with the SPPL2A
CC       protease at the cell membrane. Is internalized into multivesicular
CC       bodies of secretory lysosomes after phosphorylation by FGR and
CC       monoubiquitination. {ECO:0000250|UniProtKB:P48023}.
CC   -!- SUBCELLULAR LOCATION: [Tumor necrosis factor ligand superfamily member
CC       6, soluble form]: Secreted {ECO:0000250|UniProtKB:P48023}. Note=May be
CC       released into the extracellular fluid by cleavage from the cell
CC       surface. {ECO:0000250|UniProtKB:P48023}.
CC   -!- SUBCELLULAR LOCATION: [FasL intracellular domain]: Nucleus
CC       {ECO:0000250|UniProtKB:P48023}. Note=The FasL ICD cytoplasmic form is
CC       translocated into the nucleus. {ECO:0000250|UniProtKB:P48023}.
CC   -!- TISSUE SPECIFICITY: Expressed in activated splenocytes and thymocytes.
CC       Moderate or weak expression found in small intestines, kidney and lung.
CC       {ECO:0000269|PubMed:7505205}.
CC   -!- INDUCTION: By PMA/ionomycin and concanavalin/interleukin-2.
CC       {ECO:0000269|PubMed:7505205}.
CC   -!- PTM: The soluble form derives from the membrane form by proteolytic
CC       processing. The membrane-bound form undergoes two successive
CC       intramembrane proteolytic cleavages. The first one is processed by
CC       ADAM10 producing an N-terminal fragment, which lacks the receptor-
CC       binding extracellular domain. This ADAM10-processed FasL (FasL APL)
CC       remnant form is still membrane anchored and further processed by SPPL2A
CC       that liberates the FasL intracellular domain (FasL ICD). FasL shedding
CC       by ADAM10 is a prerequisite for subsequent intramembrane cleavage by
CC       SPPL2A in T-cells. {ECO:0000250|UniProtKB:P48023}.
CC   -!- PTM: Phosphorylated by FGR on tyrosine residues; this is required for
CC       ubiquitination and subsequent internalization.
CC       {ECO:0000250|UniProtKB:P48023}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P48023}.
CC   -!- PTM: Monoubiquitinated. {ECO:0000250|UniProtKB:P48023}.
CC   -!- SIMILARITY: Belongs to the tumor necrosis factor family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U03470; AAC52129.1; -; mRNA.
DR   PIR; A49266; A49266.
DR   RefSeq; NP_037040.1; NM_012908.1.
DR   RefSeq; XP_006250210.1; XM_006250148.3.
DR   RefSeq; XP_008767829.1; XM_008769607.2.
DR   RefSeq; XP_017454164.1; XM_017598675.1.
DR   AlphaFoldDB; P36940; -.
DR   SMR; P36940; -.
DR   STRING; 10116.ENSRNOP00000003998; -.
DR   GlyCosmos; P36940; 3 sites, No reported glycans.
DR   GlyGen; P36940; 3 sites.
DR   PhosphoSitePlus; P36940; -.
DR   PaxDb; 10116-ENSRNOP00000003998; -.
DR   Ensembl; ENSRNOT00000003998.3; ENSRNOP00000003998.2; ENSRNOG00000002978.5.
DR   Ensembl; ENSRNOT00055030011; ENSRNOP00055024103; ENSRNOG00055017740.
DR   Ensembl; ENSRNOT00060014329; ENSRNOP00060011006; ENSRNOG00060008590.
DR   Ensembl; ENSRNOT00065033401; ENSRNOP00065026716; ENSRNOG00065019821.
DR   GeneID; 25385; -.
DR   KEGG; rno:25385; -.
DR   UCSC; RGD:3880; rat.
DR   AGR; RGD:3880; -.
DR   CTD; 356; -.
DR   RGD; 3880; Faslg.
DR   eggNOG; ENOG502RXC1; Eukaryota.
DR   GeneTree; ENSGT01060000248544; -.
DR   HOGENOM; CLU_070352_2_0_1; -.
DR   InParanoid; P36940; -.
DR   OMA; THIVYKK; -.
DR   OrthoDB; 5347330at2759; -.
DR   PhylomeDB; P36940; -.
DR   TreeFam; TF332169; -.
DR   Reactome; R-RNO-3371378; Regulation by c-FLIP.
DR   Reactome; R-RNO-5218900; CASP8 activity is inhibited.
DR   Reactome; R-RNO-69416; Dimerization of procaspase-8.
DR   Reactome; R-RNO-75157; FasL/ CD95L signaling.
DR   PRO; PR:P36940; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000002978; Expressed in ileum and 8 other cell types or tissues.
DR   ExpressionAtlas; P36940; baseline and differential.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0060205; C:cytoplasmic vesicle lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0043202; C:lysosomal lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0005123; F:death receptor binding; IPI:RGD.
DR   GO; GO:0005164; F:tumor necrosis factor receptor binding; IMP:RGD.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0071346; P:cellular response to type II interferon; IEP:RGD.
DR   GO; GO:0048388; P:endosomal lumen acidification; IDA:RGD.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IMP:RGD.
DR   GO; GO:0006925; P:inflammatory cell apoptotic process; IGI:RGD.
DR   GO; GO:0030644; P:intracellular chloride ion homeostasis; IDA:RGD.
DR   GO; GO:0070266; P:necroptotic process; ISO:RGD.
DR   GO; GO:0097527; P:necroptotic signaling pathway; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:2000353; P:positive regulation of endothelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IMP:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:1905782; P:positive regulation of phosphatidylserine exposure on apoptotic cell surface; ISO:RGD.
DR   GO; GO:1903514; P:release of sequestered calcium ion into cytosol by endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0070848; P:response to growth factor; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0046666; P:retinal cell programmed cell death; ISO:RGD.
DR   GO; GO:0070231; P:T cell apoptotic process; ISO:RGD.
DR   CDD; cd00184; TNF; 1.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR028326; FASL.
DR   InterPro; IPR021184; TNF_CS.
DR   InterPro; IPR006052; TNF_dom.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   PANTHER; PTHR11471; TUMOR NECROSIS FACTOR FAMILY MEMBER; 1.
DR   PANTHER; PTHR11471:SF33; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 6; 1.
DR   Pfam; PF00229; TNF; 1.
DR   PRINTS; PR01681; FASLIGAND.
DR   SMART; SM00207; TNF; 1.
DR   SUPFAM; SSF49842; TNF-like; 1.
DR   PROSITE; PS00251; THD_1; 1.
DR   PROSITE; PS50049; THD_2; 1.
PE   2: Evidence at transcript level;
KW   Apoptosis; Cell membrane; Cytokine; Cytoplasmic vesicle; Disulfide bond;
KW   Glycoprotein; Lysosome; Membrane; Nucleus; Reference proteome; Repressor;
KW   Secreted; Signal-anchor; Transcription; Transcription regulation;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..278
FT                   /note="Tumor necrosis factor ligand superfamily member 6,
FT                   membrane form"
FT                   /id="PRO_0000034512"
FT   CHAIN           1..126
FT                   /note="ADAM10-processed FasL form"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000417163"
FT   CHAIN           1..79
FT                   /note="FasL intracellular domain"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000417164"
FT   CHAIN           127..278
FT                   /note="Tumor necrosis factor ligand superfamily member 6,
FT                   soluble form"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000034513"
FT   TOPO_DOM        1..77
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        78..99
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        100..278
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          142..278
FT                   /note="THD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01387"
FT   REGION          26..68
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          125..147
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        39..68
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        125..142
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            78..79
FT                   /note="Cleavage; by SPPL2A"
FT                   /evidence="ECO:0000250"
FT   SITE            126..127
FT                   /note="Cleavage; by ADAM10"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        116
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        247
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        257
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        199..230
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01387"
SQ   SEQUENCE   278 AA;  31140 MW;  2898E18A862CEAC6 CRC64;
     MQQPVNYPCP QIYWVDSSAT SPWAPPGSVF SCPSSGPRGP GQRRPPPPPP PPSPLPPPSQ
     PPPLPPLSPL KKKDNIELWL PVIFFMVLVA LVGMGLGMYQ LFHLQKELAE LREFTNHSLR
     VSSFEKQIAN PSTPSETKKP RSVAHLTGNP RSRSIPLEWE DTYGTALISG VKYKKGGLVI
     NEAGLYFVYS KVYFRGQSCN SQPLSHKVYM RNFKYPGDLV LMEEKKLNYC TTGQIWAHSS
     YLGAVFNLTV ADHLYVNISQ LSLINFEESK TFFGLYKL
//
